Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03707834 · ClinicalTrials.gov registry record · NA
Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 416
- Enrollment target
NCT03707834: Completed NA study, sponsored by Temple University.
NCT03707834 is a NA study that has completed, run by Temple University. The registered enrollment target is 416 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03707834, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of an antenatal obesity treatment on gestational weight gain when integrated into Philadelphia WIC.
Primary Outcome
Excessive weight gain is defined as the percentage of mothers exceeding weekly IOM weight gain targets (\>0.32 kg/week for BMI 25-29.9 kg/m2; \>0.27 kg/week for BMI ≥30 kg/m2) over the study period (from enrollment to end of pregnancy).
Interventions
- BEHAVIORAL Antenatal Obesity Treatment (AO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT03707834 record still lists
NCT03707834 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Antenatal Obesity Treatment (AO) is the first listed.
NCT03707834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03707834 about?
NCT03707834 is a clinical study titled "Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy". The purpose of this study is to determine the effect of an antenatal obesity treatment on gestational weight gain when integrated into Philadelphia WIC.
What is the current status of trial NCT03707834?
This trial is currently completed. It is a NA study. The enrollment target is 416 participants. The study started on 2018-07-01. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT03707834?
The interventions under investigation include: Antenatal Obesity Treatment (AO) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03707834?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03707834's enrollment target sits among peer trials
416 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI